Background: Chronic rhinosinusitis with nasal polyposis (CRSwNP) is an inflammatory disease associated with lymphoid aggregates and local IgE production related to Staphylococcus aureus enterotoxins. T-follicular helper cells and their effector cytokine interleukin (IL)-21 play an important role in germinal center proliferation. Methods: IL-21 was determined on the mRNA level by qPCR in nasal tissue of 3 groups of patients: control (n = 17), chronic rhinosinusitis without nasal polyposis (CRSsNP; n = 23), and CRSwNP (n = 35). The expression of IL-21 by CD4+ T cells was analyzed in tissue at baseline and after 24-h stimulation of tissue fragments with S. aureus enterotoxin B (SEB) using flow cytometry. Finally, human nasal IL-21+CXCR5+CD4+ T cells were isolated and coincubated with human blood naive B cells to investigate their functionality. Results: IL-21 mRNA expression was increased in the CRSwNP group (p < 0.05) compared to the control group, and B-cell lymphoma-6 and B-lymphocyte-induced maturation protein-1 were upregulated in CRSwNP versus CRSsNP. Furthermore, SEB was able to increase IL-21 mRNA expression significantly (p < 0.01) in nasal polyps. Flow cytometry revealed that the source of IL-21 was predominantly CD4+ T cells and that IL-21+CD4+ T cells were significantly increased in polyp tissue and further increased after SEB stimulation. Finally, tissue CXCR5+CD4+ T cells derived from nasal polyp tissue were able to induce maturation of human naive B cells. Conclusions: IL-21- and IL-21-producing CD4+ T cells were increased in CRSwNP. In addition, SEB induced an increase in IL-21 and IL-21+CD4+ T cells, suggesting that S. aureus can modulate the function of Tfh cells in nasal polyps. We speculate that T-follicular helper cells and IL-21 are important in the pathophysiology of CRSwNP.

1.
Fokkens WJ, Lund VJ, Mullol J, et al: EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012 - a summary for otorhinolaryngologists. Rhinology 2012;50:1-12.
2.
Bachert C, Zhang N, Holtappels G, et al: Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 2010;126:962-968, 968.e1-6.
3.
Van Zele T, Claeys S, Gevaert P, et al: Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006;61:1280-1289.
4.
Calus L, Zele TV, Derycke L, et al: Local inflammation in chronic upper airway disease. Curr Pharm Des 2012;18:2336-2346.
5.
Bachert C, van Steen K, Zhang N, et al: Specific IgE against Staphylococcus aureus enterotoxins: an independent risk factor for asthma. J Allergy Clin Immunol 2012;130:376-381.e8.
6.
Gevaert P, Calus L, Van Zele T, et al: Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 2013;131:110-116.e1.
7.
Gevaert P, Holtappels G, Johansson SG, Cuvelier C, Cauwenberge P, Bachert C: Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 2005;60:71-79.
8.
Nutt SL, Tarlinton DM: Germinal center B and follicular helper T cells: siblings, cousins or just good friends? Nat Immunol 2011;12:472-477.
9.
Hulse KE, Norton JE, Suh L, et al: Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression. J Allergy Clin Immunol 2013;131:1075-1083.
10.
Kato A, Hulse KE, Tan BK, Schleimer RP: B-lymphocyte lineage cells and the respiratory system. J Allergy Clin Immunol 2013;131:933-957.
11.
Gevaert P, Nouri-Aria KT, Wu H, et al: Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. Allergy 2012;68:55-63.
12.
Crotty S: Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011;29:621-663.
13.
Vinuesa CG, Linterman MA, Goodnow CC, Randall KL: T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol Rev 2010;237:72-89.
14.
Yu D, Rao S, Tsai LM, et al: The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 2009;31:457-468.
15.
Spolski R, Leonard WJ: Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008;26:57-79.
16.
Yi JS, Cox MA, Zajac AJ: Interleukin-21: a multifunctional regulator of immunity to infections. Microbes Infect 2010;12:1111-1119.
17.
Nurieva RI, Chung Y, Hwang D, et al: Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 2008;29:138-149.
18.
Bousquet J, Khaltaev N, Cruz AA, et al: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(suppl 86):8-160.
19.
Global Initiative for Asthma: Global strategy for asthma management and prevention. 2010. http://www.ginasthma.com (accessed November 24, 2011).
20.
Derycke L, Zhang N, Holtappels G, Dutre T, Bachert C: IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis. J Cyst Fibros 2012;11:193-200.
21.
Patou J, Gevaert P, Van Zele T, Holtappels G, van Cauwenberge P, Bachert C: Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008;121:110-115.
22.
Xiao L, Wei Y, Zhang YN, et al: Increased IL-21 expression in chronic rhinosinusitis with nasal polyps. Clin Exp Allergy 2015;45:404-413.
23.
Zhang YN, Song J, Wang H, et al: Nasal IL-4(+)CXCR5(+)CD4(+) T follicular helper cell counts correlate with local IgE production in eosinophilic nasal polyps. J Allergy Clin Immunol 2016;137:462-473.
24.
Kim CH, Lim HW, Kim JR, Rott L, Hillsamer P, Butcher EC: Unique gene expression program of human germinal center T helper cells. Blood 2004;104:1952-1960.
25.
Rasheed AU, Rahn HP, Sallusto F, Lipp M, Muller G: Follicular B helper T cell activity is confined to CXCR5(hi)ICOS(hi) CD4 T cells and is independent of CD57 expression. Eur J Immunol 2006;36:1892-1903.
26.
Ma CS, Suryani S, Avery DT, et al: Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol Cell Biol 2009;87:590-600.
27.
Kroenke MA, Eto D, Locci M, et al: Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol 2012;188:3734-3744.
28.
Crotty S, Johnston RJ, Schoenberger SP: Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation. Nat Immunol 2010;11:114-120.
29.
Ohkawara Y, Lim KG, Xing Z, et al: CD40 expression by human peripheral blood eosinophils. J Clin Invest 1996;97:1761-1766.
30.
Van Bruaene N, Perez-Novo CA, Basinski TM, et al: T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008;121:1435-1441, 1441.e1-3.
31.
Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P: Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001;107:607-614.
32.
Zhang N, Holtappels G, Gevaert P, et al: Mucosal tissue polyclonal IgE is functional in response to allergen and SEB. Allergy 2011;66:141-148.
33.
Bryant VL, Ma CS, Avery DT, et al: Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol 2007;179:8180-8190.
34.
Van Zele T, Gevaert P, Holtappels G, van Cauwenberge P, Bachert C: Local immunoglobulin production in nasal polyposis is modulated by superantigens. Clin Exp Allergy 2007;37:1840-1847.
35.
Mechtcheriakova D, Sobanov Y, Holtappels G, et al: Activation-induced cytidine deaminase (AID)-associated multigene signature to assess impact of AID in etiology of diseases with inflammatory component. PLoS One 2011;6:e25611.
36.
Morita R, Schmitt N, Bentebibel SE, et al: Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011;34:108-121.
37.
Bentebibel SE, Schmitt N, Banchereau J, Ueno H: Human tonsil B-cell lymphoma 6 (BCL6)-expressing CD4+ T-cell subset specialized for B-cell help outside germinal centers. Proc Natl Acad Sci USA 2011;108:E488-E497.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.